Empty Uterus at 7 Weeks: Confirming Location Before Anyone Reaches for Methotrexate
EMS brings a 29-year-old G3P1 to the emergency department at 20:40 on a Friday with 3 days of cramping and scant dark vaginal bleeding. Her LMP places her at 7 weeks 4 days and her cycles are regular. A quantitative beta-hCG drawn 18 hours earlier is 3,250 mIU/mL. Because the department's transvaginal probe is being used elsewhere, the on-call sonographer performs a transabdominal scan with a curved array: the uterus is empty apart from a 6-mm anechoic collection within the cavity, and a 2.8-cm simple cyst sits in the right adnexa. There is a trace of fluid in the cul-de-sac. Vital signs are stable, haemoglobin is 128 g/L, and the patient is Rh-negative. She is a night-shift warehouse supervisor who drove 70 minutes to be there and asks whether she can "just have the methotrexate shot tonight" so she does not have to come back before her next shift. The emergency physician asks you to "confirm the ectopic" before the patient leaves.
1. What does the transabdominal study actually establish, and what is your next imaging step? Show how you use the beta-hCG value in that decision.
Read the worked answer
The scan establishes exactly one thing: no gestational sac is visible in the uterus. It does not establish an ectopic pregnancy, and the request to "confirm the ectopic" cannot be met from a transabdominal image in a patient with a body habitus and bowel gas pattern that are not described.
Using the hCG: 3,250 mIU/mL sits at the edge of most discriminatory zones (3,000-3,500 mIU/mL). The zone is a probabilistic rule, not a threshold that proves anything. It shifts with the assay, and hCG runs higher than expected in multiple gestations and in some molar pregnancies. Critically, a single value says nothing about trend, and a normal early intrauterine pregnancy can be present with a value that has not yet doubled.
The 6-mm cavity collection is the finding that most needs adjudication. Its location relative to the endometrial stripe, whether it conforms to and moves with the endometrium, and whether a yolk sac is present are what separate a pseudogestational sac from a true sac. The 2.8-cm simple right adnexal cyst is most likely a corpus luteum and should not be labelled an ectopic; a tubal ectopic is usually a separate, more complex structure, often with a thick echogenic rim, sometimes a yolk sac or fetal pole, and often tender.
Next step: a transvaginal scan by an experienced operator, in the same visit, with colour Doppler of the adnexa and the interstitial region. If it shows no intrauterine and no extrauterine pregnancy, the diagnosis is pregnancy of unknown location and the pathway is serial hCG at 48 hours, not treatment.
2. The patient asks for methotrexate tonight. How do you respond, and what must be established before any treatment decision is made?
Read the worked answer
The answer is no, and the reasoning should be given to her plainly rather than as a policy statement.
First, the pregnancy's location is undetermined. Methotrexate is an antimetabolite that will injure or kill an intrauterine pregnancy. Giving it before an ectopic is demonstrated risks terminating a wanted or viable intrauterine pregnancy, and it is precisely the situation in which the drug should not be used. 'Presumed ectopic' is not an indication.
Second, even a confirmed ectopic has to meet criteria before methotrexate is appropriate, and those criteria are local but broadly consistent: haemodynamic stability, no evidence of rupture or significant free fluid, a mass below the size limit used by the institution (commonly 3.5-4 cm), no fetal cardiac activity, an hCG below the local ceiling, no contraindication such as renal or hepatic impairment, blood dyscrasia, active pulmonary disease, or inability to comply with follow-up. Baseline full blood count, renal and liver function, and blood group should be available.
Third, she has described a follow-up problem, and that is a clinical issue rather than an inconvenience. Methotrexate requires hCG on day 4 and day 7, a second dose in roughly 15% of patients, and it fails in a proportion who then need surgery, sometimes urgently with a ruptured tube. A patient who cannot return is at real risk. If an ectopic is confirmed, that constraint has to shape the plan, including the option of surgical management, rather than being worked around.
Rh status: if an ectopic pregnancy is confirmed and managed, anti-D immunoglobulin should be given according to local protocol. It is not a reason to treat tonight on its own.
3. How would you distinguish a pseudogestational sac from a true gestational sac in this patient, and what would make you confident that an ectopic pregnancy is present?
Read the worked answer
A pseudogestational sac is fluid within the endometrial cavity, not a pregnancy. It tends to sit centrally in the cavity, may be irregular or elongated, changes shape and position with the endometrium when the uterus is moved, has no double decidual sign, and never contains a yolk sac, however small. It is common in ectopic pregnancy because the hormonal environment produces secretory endometrium, which is exactly why it is dangerous: it can be mistaken for a sac and delay the diagnosis.
A true gestational sac is eccentric, embedded in the endometrium on one side, surrounded by the echogenic double decidual ring, and grows. The definitive discriminator is a yolk sac, which is visible transvaginally from around 5.5 weeks and transabdominally much later.
The findings that would make me confident of a tubal ectopic are: an adnexal mass separate from the ovary and separate from the corpus luteum, with a thick echogenic rim, tender on probe pressure; an empty uterus with an hCG above the discriminatory zone on a technically adequate transvaginal scan; and free fluid, particularly echogenic fluid suggesting blood. Colour Doppler showing a vascular ring around the mass supports but does not prove the diagnosis, and a 'ring of fire' can be seen around a corpus luteum.
I would also look specifically at the interstitial region. A sac located eccentrically, more than 5 mm from the fundal serosa, with a thin myometrial mantle, suggests an interstitial pregnancy, which is managed differently and can bleed catastrophically. In this patient the single transabdominal image cannot distinguish any of these, which is the point.